CRNX

CRNX Operating Cash Flow Growth

-40.94%TTM

Period ending:

CRNX TTM Cash from Operations YoY %%
CRNX TTM Cash from Operations YoY %3.16%-159.89%
2018-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CRNX operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 31 observations from Dec 31, 2018 to Jun 30, 2026.

Crinetics Pharmaceuticals Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-40.945%
-58.3436%
-67.2443%
-75.0129%
-66.2137%
-46.5807%
-35.8752%
-22.5842%
-12.6234%
-25.3301%
-44.3574%
-58.4099%
-77.7525%
-73.4987%
-30.0458%
-26.0576%
-21.8137%
-17.4625%
-42.8217%
-37.1053%
-34.1301%
-34.7373%
-33.7336%
-52.8799%
-77.7015%
-127.3114%
-138.3524%
-143.9885%
-144.1114%
-116.0133%
-105.2854%

Compare operating cash flow growth

All CRNX financial metrics · CRNX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.